Publications by authors named "Sheri L Booten"

Claim this Profile
A
Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.
Ya-Wen Yang, Bibek Poudel, Julia Frederick, Poonam Dhillon, Rojesh Shrestha, Sheri L Booten

Mol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
Mara Caputo, Yeshwant Kurhe, Sima Kumari, Emmelie Cansby, Manoj Amrutkar, Sheri L Booten

FASEB J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Emmelie Cansby, Esther Nuñez-Durán, Elin Magnusson, Manoj Amrutkar, Sheri L Booten

Cell Mol Gastroenterol Hepatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotide treatment ameliorates IFN-γ-induced proteinuria in APOL1-transgenic mice.
Mariam Aghajan, Sheri L Booten, Magnus Althage, Christopher E Hart, Anette Ericsson

JCI Insight· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
Esther Nuñez-Durán, Mariam Aghajan, Manoj Amrutkar, Silva Sütt, Emmelie Cansby, Sheri L Booten

Hepatol Commun· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes.
Thazha P Prakash, Jinghua Yu, Michael T Migawa, Garth A Kinberger, W Brad Wan, Sheri L Booten

J Med Chem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
Thazha P Prakash, Mark J Graham, Jinghua Yu, Rick Carty, Audrey Low, Sheri L Booten

Nucleic Acids Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.
Shuling Guo, Sheri L Booten, Andrew Watt, Luis Alvarado, Susan M Freier

Rare Dis· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.
Shuling Guo, Sheri L Booten, Mariam Aghajan, Gene Hung, Chenguang Zhao

J Clin Invest· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys.
Michael M Swarbrick, Peter J Havel, Arthur A Levin, Andrew A Bremer, Kimber L Stanhope, Sheri L Booten

Endocrinology· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
Xing Xian Yu, Susan F Murray, Lynnetta Watts, Sheri L Booten, Justin Tokorcheck

Am J Physiol Endocrinol Metab· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
Xing Xian Yu, Sanjay K Pandey, Sheri L Booten, Susan F Murray, Brett P Monia

Am J Physiol Endocrinol Metab· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.
Kyle W Sloop, Aaron D Showalter, Amy L Cox, Julia X C Cao, Angela M Siesky, Sheri L Booten

J Biol Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
Christine Esau, Scott Davis, Susan F Murray, Xing Xian Yu, Sanjay K Pandey, Sheri L Booten

Cell Metab· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Xing Xian Yu, Susan F Murray, Sanjay K Pandey, Sheri L Booten, Dingjiu Bao

Hepatology· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis